|
Company:
|
IMPAX LABORATORIES INC (IPXL)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
4/9/2009
|
|
CIK:
|
0001003642
|
|
Address:
|
30831 HUNTWOOD AVENUE
|
|
City, State, Zip:
|
HAYWARD, California 94544
|
|
Telephone:
|
(510) 476-2000
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$13.66
|
Change:
0.02 (0.15%)
|
Trade Time:
Feb 09
|
Market Cap:
$845.21M
|
|
|
|
|
Description of Business
|
|
Impax Laboratories, Inc. ("we," "us," "our," "the Company" or "IMPAX") is a
technology based, specialty pharmaceutical company focused on the development
and commercialization of generic and brand name pharmaceuticals, utilizing our
controlled-release and other in-house development and formulation expertise. In
the generic pharmaceuticals market, we focus our efforts on controlled-release
generic versions of selected brand name pharmaceuticals across a broad range of
therapeutic areas. We are also developing specialty generic pharmaceuticals
which we believe present one or more competitive barriers to entry, such as
difficulty in raw materials sourcing, complex formulation or development
characteristics, or special handling requirements. In the brand name
pharmaceuticals market, we are developing products for the treatment of central
nervous system, or CNS disorders.
|
|
|
|